Pediatric heart transplantation-Indications and outcomes in the current era

Philip T. Thrush*, Timothy M. Hoffman

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

57 Scopus citations


Pediatric heart transplantation (HTx) remains an important treatment option in the care of children with end-stage heart disease, whether it is secondary to cardiomyopathy or congenital heart disease (CHD). As surgical outcomes for CHD have improved, the indications for pediatric HTx have had to be dynamic, not only for children with CHD but also for the growing population of adults with CHD. As the field of pediatric HTx has evolved, the outcomes for children undergoing HTx have improved. This is undoubtedly due to the continued research efforts of both single-center studies, as well as research collaboratives such as the International Society for Heart and Lung Transplantation (ISHLT) and the Pediatric Heart Transplant Study (PHTS) group. Research collaboratives are increasingly important in pediatric HTx as single center studies for a limited patient population may not elicit strong enough evidence for practice evolution. Similarly, complications that limit the long term graft survival may occur in a minority of patients thus pooled experience is essential. This review focuses on the indications and outcomes for pediatric HTx, with a special emphasis on studies generated by these research collaboratives.

Original languageEnglish (US)
Pages (from-to)1080-1096
Number of pages17
JournalJournal of Thoracic Disease
Issue number8
StatePublished - 2014


  • Cardiomyopathy
  • Congenital heart defects
  • Graft rejection
  • Graft survival
  • Heart transplantation (HTx)
  • Pediatrics

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine


Dive into the research topics of 'Pediatric heart transplantation-Indications and outcomes in the current era'. Together they form a unique fingerprint.

Cite this